U.S. Stock News

NYSE:BVN
NYSE:BVNMetals and Mining

Buenaventura Permits And San Gabriel Ramp Up Reframe Earnings Outlook

Compañía de Minas BuenaventuraA (NYSE:BVN) reported multiple operational and permitting milestones in Q1 2026, including the production ramp up at San Gabriel. The company received key stage 1 operating and water use permits for San Gabriel, while Yumpag and El Brocal secured capacity expansion approvals. Gold production, company wide revenue, and profitability all saw significant gains in the quarter, alongside these project advances. For investors watching NYSE:BVN, these updates come...
NasdaqCM:GRRR
NasdaqCM:GRRRSoftware

Gorilla Technology Group (GRRR) Is Up 17.9% After $2.8 Billion India AI Infrastructure Expansion

In recent days, Gorilla Technology Group Inc. announced a significant expansion of its India AI infrastructure collaboration with Yotta Data Services, supporting the deployment of 20,736 additional B300 GPU cards in a multi-year project valued at about US$2.80 billion, alongside a deeper investment in real-time infrastructure intelligence firm Astrikos.AI. This combination of a very large GPU deployment tied to one of APAC’s largest NVIDIA DGX Cloud clusters and closer Astrikos.AI...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Is It Too Late To Consider Travere Therapeutics (TVTX) After Its Strong Share Price Rally?

Wondering whether Travere Therapeutics at around US$44.12 is still offering value or if the easy gains are already behind it? This article unpacks what the current price really implies. The stock has shown strong share price moves, with returns of 8.9% over 7 days, 40.4% over 30 days, 11.6% year to date, 108.6% over 1 year, 162.6% over 3 years and 120.5% over 5 years. This naturally raises questions about both upside potential and risk. Recent headlines around Travere Therapeutics have...
NYSE:CWEN.A
NYSE:CWEN.ARenewable Energy

Did Clearway’s Shift to a Single Class C Share and Index Exit Just Reframe (CWEN.A)’s Investment Narrative?

Clearway Energy, Inc. has already converted all of its Class A common stock into Class C common stock as of May 1, 2026, with Class A trading suspended and Class C now trading on the New York Stock Exchange. This simplification of the public share structure, alongside Clearway’s simultaneous removal from numerous major Russell and S&P indexes, reshapes how index funds and active investors may gain exposure to the company. We’ll now examine how Clearway’s shift to a single Class C share...
NYSE:LOW
NYSE:LOWSpecialty Retail

Lowe's Pro Card Expansion Aims To Deepen Contractor Spend And Insights

Synchrony and Lowe's Companies have expanded their partnership with the launch of the MyLowe's Pro Rewards American Express Card. The new co branded card extends purchasing power and rewards for professional customers beyond Lowe's stores to any location where American Express is accepted. The offering targets small to medium business customers within Lowe's Pro segment, with a focus on broader rewards and financing flexibility. Lowe's Companies, NYSE:LOW, is trading at $233.33, with the...
NYSE:SOC
NYSE:SOCOil and Gas

How Federal-Backed Pipeline Restart And Insider Stock Activity At Sable Offshore (SOC) Has Changed Its Investment Story

Sable Offshore Corp. recently resumed oil transportation through key pipeline segments and expanded drilling activity after federal intervention resolved prior regulatory hurdles that had stalled production in 2025. Alongside this operational restart, the company’s executives converted large blocks of restricted stock units and sold shares mainly to cover tax obligations, underscoring substantial ongoing insider equity exposure. We’ll now examine how the resumption of oil production...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Sprouts Expansion And Pricing Moves Reshape Growth Outlook For Investors

Sprouts Farmers Market is opening its first New York store as part of an accelerated nationwide rollout. The company plans more than 40 new locations in 2026, expanding its footprint beyond existing core regions. Management is rolling out targeted price adjustments, loyalty program efforts, and supply chain work to support long term growth after recent comparable sales declines. Sprouts Farmers Market, NasdaqGS:SFM, is pushing into new territory with its New York entry while ramping up...
NYSE:CCL
NYSE:CCLHospitality

Carnival Ransomware Breach Puts Data Security And Share Valuation In Focus

Carnival Corporation & (NYSE:CCL) has been hit by a significant ransomware attack linked to the hacking group ShinyHunters. The incident reportedly involves more than 8,700,000 records containing sensitive personal data. Multiple class action lawsuits have been filed, alleging weak cybersecurity controls and slow notification to affected individuals. The breach is drawing fresh attention to the company’s data security practices and operational risk. Carnival Corporation & enters this data...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives

Bristol-Myers Squibb (BMY) opened 2026 with Q1 revenue of US$11.5b, basic EPS of US$1.31 and net income of US$2.7b, setting the tone for how investors will judge its recent profitability. The company has seen quarterly revenue move from US$11.2b and basic EPS of US$1.21 in Q1 2025 to US$11.5b and US$1.31 in Q1 2026. Trailing twelve month EPS reached US$3.57, giving a clearer read on earnings power over the last year. With trailing net profit margin at 15% and recent earnings growth of 34.2%...
NYSE:EMN
NYSE:EMNChemicals

Eastman Chemical Q1 2026 Margin Compression Tests Bullish Earnings Growth Narrative

Eastman Chemical Q1 2026 earnings: headline numbers in focus Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6%...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Assessing Phibro Animal Health (PAHC) Valuation After Strong Recent Share Price Momentum

Why Phibro Animal Health stock is on investors’ radar Recent trading in Phibro Animal Health (PAHC) has drawn attention, with the share price at $54.89 and total return data over the past month and past 3 months prompting closer scrutiny of the business fundamentals. See our latest analysis for Phibro Animal Health. That recent one day share price return of 3.22% sits on top of a 36.71% 90 day share price return and a very large 1 year total shareholder return, which suggests momentum has...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Does Recursion’s 2026 Update And Board Shift Reframe Its AI Drug Discovery Ambitions For RXRX?

Recursion Pharmaceuticals recently confirmed it will report first-quarter 2026 results and business updates on May 6, 2026, with a publicly accessible earnings call allowing questions from investors and the broader community. At the same time, the company flagged leadership changes, including Chris Gibson, Ph.D., stepping down from the Board in June 2026 while remaining an advisor, underscoring an emphasis on continuity and its AI-driven drug discovery platform. We’ll examine how the...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

T. Rowe Price Group (TROW) Margin Stability Reinforces Income Narrative Despite Q1 AUM Outflows

T. Rowe Price Group (TROW) opened 2026 with Q1 revenue of US$1.9 billion and basic EPS of US$2.23, alongside trailing twelve month revenue of US$7.4 billion and EPS of US$9.34 that sit against modest 1.9% annual revenue growth and a 27.6% net profit margin over the past year. Over recent quarters, revenue has ranged from US$1.7 billion to US$1.9 billion, while quarterly EPS has moved between roughly US$1.93 and US$2.88. This provides a consistent picture of earnings power, even as the five...
NYSE:ENS
NYSE:ENSElectrical

Assessing EnerSys (ENS) Valuation After A Strong Year Of Share Price Momentum

Why EnerSys Is On Investors’ Radar Today EnerSys (ENS) has caught attention after a strong run over the past year, prompting investors to reassess what the current share price might already reflect about its business mix and fundamentals. See our latest analysis for EnerSys. Recent trading has been dominated by strong momentum, with a 19.4% 1 month share price return and 40.9% year to date share price return contributing to a 136.0% 1 year total shareholder return. This points to shifting...
NYSE:DRI
NYSE:DRIHospitality

Smokey Bones Closure Puts Darden Restaurants Valuation And Brand Decisions In Focus

Smokey Bones, the barbecue chain originally founded by Darden Restaurants, has been fully closed after a 27 year run. The shutdown ends a long standing brand legacy that traces back to Darden’s earlier expansion in American casual dining. Although Darden no longer owns Smokey Bones, the closure adds context for investors tracking NYSE:DRI and the broader barbecue and casual dining space. Darden Restaurants, trading as NYSE:DRI, is coming off a mixed share performance backdrop, with the...
NYSE:KIM
NYSE:KIMRetail REITs

Is Kimco Realty (KIM) Offering Value After Mixed Multi Year Share Price Performance

If you are wondering whether Kimco Realty's current share price lines up with its underlying value, this article walks through the key numbers so you can judge that for yourself. Over recent periods the stock has seen mixed returns, with a 1.3% decline over the last 7 days, a 4.1% gain over 30 days, 16.6% year to date, 16.0% over 1 year, 43.7% over 3 years and 35.3% over 5 years. Recent coverage of Kimco Realty has focused on its role as a large retail REIT and how investors are weighing...